# SMIM Paper Review Prompt — Round 3 (Final Pre-Submission)

Paste the full LaTeX source of the paper above this prompt.

---

## Prompt

You are a single senior referee conducting a **final acceptance review** for a manuscript at the *Journal of Business & Economic Statistics*. The paper has been through two prior rounds. Most substantive concerns have been addressed: the Kalman filter algebra is corrected, the placebo is at 1000 permutations, the FRED look-ahead and SEC filing lag have both been computationally tested, the block selection is honestly framed as exploratory, and 10-candidate transparency is provided. Your job is no longer to find fatal flaws — it is to determine whether the paper is ready for publication **as-is**, or whether specific remaining issues must be fixed first.

You are an expert in panel forecasting, factor models, and empirical methodology. You have published on Diebold-Mariano tests, heterogeneous panels, and out-of-sample forecast evaluation. You have read the previous referee reports and know what was already addressed. You are fair but exacting on final-round details.

---

### What to look for in a final-round review

At this stage, the questions are:

1. **Is every number in the paper internally consistent?** Cross-check key statistics across tables, text, abstract, and appendices. If the abstract says +0.047 but a table says +0.046, flag it.

2. **Does every claim have quantitative support?** If the text says "robust" or "survives," there should be a number, a CI, or a test within one paragraph. Verbal assertions without nearby evidence are not acceptable at this stage.

3. **Are there any remaining logical gaps in the argument?** The paper's thesis is: global pooling helps for persistence, local decomposition helps for residual dynamics, the gain requires data-type heterogeneity. Does every section contribute to this thesis? Is there anything that contradicts it or is left unexplained?

4. **Is the paper self-contained?** Could a reader who has never seen the prior rounds understand every table, every figure, every claim? Are forward/backward references clear? Are all notation and acronyms defined on first use?

5. **Is the tone appropriate for the claimed contribution?** An exploratory finding with strong internal validation is valuable, but the language should not read like a theorem. Check: abstract, introduction, conclusion — do they match the evidence level?

---

### Specific audit items

**Numbers and consistency:**
- The abstract says $\Delta = +0.047$, CI $[+0.036, +0.058]$. Verify these match Table 5 exactly.
- The abstract says the gain is "concentrated in the tech/health block (~72%)." Verify: is 72% computed as (0.047 - 0.013) / 0.047? If so, this assumes the drop-tech/health gain (0.013) comes entirely from non-tech/health blocks, which may not be exact due to cross-block interaction effects. Is there a cleaner way to state the concentration?
- Table 2 reports the 93-actor augmentation gain as +0.036. Table 5 reports M2 vs G1 as +0.047. The difference (+0.047 vs +0.036) is because Table 2 compares augmented vs AR(1) while Table 5 compares M2 vs G1. Is this explained clearly enough that a reader won't confuse them?
- Section 5.9 reports the filing-lag G1 R² as 0.639, which is *higher* than the contemporaneous 0.630. The text explains this as "staler firm data is easier to predict when targets are also stale." Is this explanation quantitatively coherent? If predictions and targets are both lagged, shouldn't R² *decrease* due to information loss?
- Appendix H: Diversified has $\Delta = +0.014$ (8/10), but the drop-diversified test in Section 5.4 shows the remaining gain without diversified is +0.035 (from a +0.047 baseline). That means diversified contributes +0.012 to the mixture, not +0.014. Reconcile: the +0.014 is from a single-block-local test while +0.012 is the marginal contribution in the three-block mixture. Is this distinction clear?

**Claims without quantitative support:**
- "The architectural differential is robust to real-time data availability" (Section 5.9). Under the lag, $\Delta$ drops from +0.047 to +0.038 — a 19% decline. Is "robust" the right word for a 19% drop? Should there be a formal test (paired difference with CI) on the 0.047 vs 0.038?
- "Adding local treatment to the remainder provides no empirical benefit" (Section 5.7). The four-block mixture gives +0.043 vs three-block +0.047. Is a -0.004 difference "no benefit" or "slight degradation"? Is there a CI?
- "The K_b values in Table 4 are robust to the choice of T" (Section 7.4). This claim is supported by Table 10 but without a formal sensitivity test. Is the claim too strong for a descriptive grid?
- The per-block R² in Table 6 for tech/health reaches 0.808 under M2. This is extraordinarily high for cross-sectional percentile ranks. Is this number plausible? What is the corresponding RMSE?

**Structural and logical:**
- The paper has 10 validation subsections (5.1-5.10). Is this too many? Would some be better as appendix material? The paper already has 8 appendices (A-H). Does the validation section read as overkill, or does each subsection earn its place?
- Section 6 ("What Does Not Work") presents four falsification tests. Table 9 summarises them. But the mixture gain (+0.047) is itself a positive result from Section 4 — so Section 6 is falsifying alternatives to explain the *ceiling* (0.630), not the mixture gain. Is this clear, or could a reader confuse the two?
- The pre-registered predictions in Section 7.5 are about the T×K_b sweep, not about the headline M2-vs-G1 result. Does the paper make this scope clear? Could a reader think the headline result itself was pre-registered?

**Writing and presentation:**
- Count the number of $R^2$ values reported in the paper. Is there a risk of information overload? Which tables are essential and which could be moved to appendices?
- The paper uses "actors" throughout instead of the more common "units" or "cross-sectional entities." Is this terminology clear to an econometrics audience, or does it require more initial explanation?
- Check all figure references: does each figure reference in the text match an actual figure? Are figures referenced before they appear?
- Check the abstract length. For JBES, the typical limit is ~150 words. How long is this abstract?

**Final verdict items:**
- Name the single weakest paragraph in the paper — the one that would benefit most from rewriting.
- Name the single strongest section — the one that most clearly earns the paper's contribution claim.
- If you had to cut 2 pages from the paper for length, which material would you move to an online supplement?

---

### Output format

```
## Final Referee Report

### 1. Numbers and Consistency
[Item-by-item audit with verdicts: Correct / Minor inconsistency / Error]

### 2. Unsupported Claims
[List of claims that need quantitative backing, with suggested fixes]

### 3. Logical Structure
[Assessment of the argument flow, section organisation, scope clarity]

### 4. Writing and Presentation
[Tone calibration, terminology, length, figure/table management]

### 5. Verdict
Weakest paragraph: [location and why]
Strongest section: [location and why]
Material to cut for length: [specific sections/tables]

Overall: [Accept / Accept with minor edits / Minor revision]
[If not accept: numbered list of required changes, max 5 items]
```

Be specific. Every comment should reference a line, equation, table, or section number. If you find no issues in a category, say "No issues found" rather than inventing complaints.
